# FABREC breast reconstruction radiotherapy

Source: https://onco.cc/trials/nct03422003/  
OnCo record `nct03422003` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

FABREC compares shorter-course with conventional radiation after mastectomy and reconstruction. It measures patient-reported outcomes and effects on reconstruction and cancer control.

## Summary

FABREC compares shorter-course with conventional radiation after mastectomy and reconstruction. It measures patient-reported outcomes and effects on reconstruction and cancer control.

Interventional study registered as NCT03422003, sponsored by Dana-Farber Cancer Institute. No drug-development phase applies in the structured registry record. Registry enrollment is 400 participants (actual). Registry status checked October 10, 2026: active not recruiting. UCSF lists this study as closed to local enrollment; local availability and overall registry status are separate. See the registry for full eligibility and current sites.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-10-10
- Also known as: Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma
- Tags: ucsf-breast-coverage; interventional
- Registry id: NCT03422003
- Phase: not-applicable
- Setting: Breast cancer after mastectomy and immediate reconstruction
- Sponsor: Dana-Farber Cancer Institute
- Enrolled: 400

## Sources

- ClinicalTrials.gov NCT03422003: https://clinicaltrials.gov/study/NCT03422003
- UCSF study listing and local availability: https://clinicaltrials.ucsf.edu/trial/NCT03422003

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/)
- institutions: [UCSF Helen Diller Family Comprehensive Cancer Center](https://onco.cc/institutions/ucsf/)

---
JSON: https://onco.cc/api/v1/entities/nct03422003.json